this post was submitted on 27 Feb 2025
186 points (99.5% liked)
Technology
63313 readers
4997 users here now
This is a most excellent place for technology news and articles.
Our Rules
- Follow the lemmy.world rules.
- Only tech related content.
- Be excellent to each other!
- Mod approved content bots can post up to 10 articles per day.
- Threads asking for personal tech support may be deleted.
- Politics threads may be removed.
- No memes allowed as posts, OK to post as comments.
- Only approved bots from the list below, to ask if your bot can be added please contact us.
- Check for duplicates before posting, duplicates may be removed
- Accounts 7 days and younger will have their posts automatically removed.
Approved Bots
founded 2 years ago
MODERATORS
you are viewing a single comment's thread
view the rest of the comments
view the rest of the comments
Both your other question and this one and irrelevant to discussion, which is me refuting that GenAI is “dead end”. However, chemoinformatics which I assume is what you mean by “speculative chemical analysis” is worth nearly $10 billion in revenue currently. Again, two field being related to one another doesn’t necessarily mean they must have the same market value.
Right, and what percentage of their expenditures is software tooling?
Who's paying for this shit? Anybody? Who's selling it without a loss? Anybody?
Boy these goalpost sure are getting hard to see now.
Is anybody paying for ChatGPT, the myriad of code completion models, the hosting for them, dialpadAI, Sider and so on? Oh I’m sure one or two people at least. A lot of tech (and non tech) companies, mine included, do so for stuff like Dialpad and sider off the top of my head.
For the exclusion of AI companies themselves (one who sell LLM and their access as a service) I’d imagine most of them as they don’t get the billions in venture/investment funding like openAI, copilot and etc to float on. We usually only see revenue not profitability posted by companies. Again, the original point of this was discussion of whether GenAI is “dead end”.
Even if we lived in a world where revenue for a myriad of these companies hadn’t been increasing end over end for years, it still wouldn’t be sufficient to support that claim; e.g. open source models, research inside and out of academia.